Value for Money in Ukraine’s HIV Response : Strategic Investment and Improved Efficiency
Ukraine experiences one of the most severe HIV epidemics in Europe. An HIV allocative efficiency analysis has been carried out, which revealed that there are several key opportunities to change the course of Ukraine’s HIV epidemic:Ukraine’s current...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Working Paper |
| Language: | English en_US |
| Published: |
World Bank, Washington, DC
2016
|
| Subjects: | |
| Online Access: | http://documents.worldbank.org/curated/en/2016/07/26570650/value-money-ukraine’s-hiv-response-strategic-investment-improved-efficiency http://hdl.handle.net/10986/24967 |
| id |
okr-10986-24967 |
|---|---|
| recordtype |
oai_dc |
| spelling |
okr-10986-249672021-06-14T10:19:12Z Value for Money in Ukraine’s HIV Response : Strategic Investment and Improved Efficiency World Bank Goroshko, Alona Benedikt, Clemens Wilson, David Masaki, Emiko Görgens, Marelize Belli, Paolo HIV health financing health expenditure antiretroviral therapy Ukraine experiences one of the most severe HIV epidemics in Europe. An HIV allocative efficiency analysis has been carried out, which revealed that there are several key opportunities to change the course of Ukraine’s HIV epidemic:Ukraine’s current HIV response already makes strategic use of available resources (around US$80 million in 2013) prioritizing Antiretroviral Therapy (ART) and prevention programs for people who inject drugs (PWID), men who have sex with men (MSM) and female sex workers (FSW). This investment, which successfully stabilized the epidemic – although at a high level – is unlikely to lead to further declines in new infections and deaths. The number of people on ART could be doubled to 130,000 (around 60 percent of all PLHIV) within the stipulated annual budget. At the time of completion of this study (mid 2015), only around 30 percent of Ukraine’s estimated 223,000 PLHIV received treatment against a global target of 81 percent by 2020. There is need to implement efficient and effective ART scale-up, achieve the national target of 118,240 PLHIV on ART by 2018, and plan for further increasing coverage to reach global targets - with a strong focus on HIV diagnosis among key populations.Continued funding for prevention programs for key populations remains critical beyond 2018.There is need for enhanced integration of HIV services with services for Tuberculosis, drug use treatment including Opioid Substitution Therapy, blood-borne viruses and sexual health.Ukraine’s HIV response requires a shared long-term vision on sustainable HIV financing and needs to harness the wider health sector reforms and emerging financing models. This policy brief is a result of a team effort involving the State Institution Ukrainian Center for Socially Dangerous Disease Control of the MOH of Ukraine and international partners. The study was part of the regional initiatives on HIV allocative efficiency analysis and funded and technically supported by the World Bank and UNAIDS. We greatly acknowledge the contributions of all the team members, stakeholders and other partners. There are major opportunities, but also major risks in relation to HIV investment decisions in Ukraine in the coming five years. While decreasing funding would lead to a marked increase in deaths, new infections and future health care costs, a smart approach to increasing HIV investment, could avert around half of the new infections and deaths up to 2030 compared to business as usual. 2016-08-29T16:54:24Z 2016-08-29T16:54:24Z 2016-03-01 Working Paper http://documents.worldbank.org/curated/en/2016/07/26570650/value-money-ukraine’s-hiv-response-strategic-investment-improved-efficiency http://hdl.handle.net/10986/24967 English en_US CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo/ World Bank World Bank, Washington, DC Publications & Research Publications & Research :: Working Paper Europe and Central Asia Ukraine |
| repository_type |
Digital Repository |
| institution_category |
Foreign Institution |
| institution |
Digital Repositories |
| building |
World Bank Open Knowledge Repository |
| collection |
World Bank |
| language |
English en_US |
| topic |
HIV health financing health expenditure antiretroviral therapy |
| spellingShingle |
HIV health financing health expenditure antiretroviral therapy World Bank Value for Money in Ukraine’s HIV Response : Strategic Investment and Improved Efficiency |
| geographic_facet |
Europe and Central Asia Ukraine |
| description |
Ukraine experiences one of the most
severe HIV epidemics in Europe. An HIV allocative efficiency
analysis has been carried out, which revealed that there are
several key opportunities to change the course of Ukraine’s
HIV epidemic:Ukraine’s current HIV response already makes
strategic use of available resources (around US$80 million
in 2013) prioritizing Antiretroviral Therapy (ART) and
prevention programs for people who inject drugs (PWID), men
who have sex with men (MSM) and female sex workers (FSW).
This investment, which successfully stabilized the epidemic
– although at a high level – is unlikely to lead to further
declines in new infections and deaths. The number of people
on ART could be doubled to 130,000 (around 60 percent of all
PLHIV) within the stipulated annual budget. At the time of
completion of this study (mid 2015), only around 30 percent
of Ukraine’s estimated 223,000 PLHIV received treatment
against a global target of 81 percent by 2020. There is need
to implement efficient and effective ART scale-up, achieve
the national target of 118,240 PLHIV on ART by 2018, and
plan for further increasing coverage to reach global targets
- with a strong focus on HIV diagnosis among key
populations.Continued funding for prevention programs for
key populations remains critical beyond 2018.There is need
for enhanced integration of HIV services with services for
Tuberculosis, drug use treatment including Opioid
Substitution Therapy, blood-borne viruses and sexual
health.Ukraine’s HIV response requires a shared long-term
vision on sustainable HIV financing and needs to harness the
wider health sector reforms and emerging financing models.
This policy brief is a result of a team effort involving the
State Institution Ukrainian Center for Socially Dangerous
Disease Control of the MOH of Ukraine and international
partners. The study was part of the regional initiatives on
HIV allocative efficiency analysis and funded and
technically supported by the World Bank and UNAIDS. We
greatly acknowledge the contributions of all the team
members, stakeholders and other partners. There are major
opportunities, but also major risks in relation to HIV
investment decisions in Ukraine in the coming five years.
While decreasing funding would lead to a marked increase in
deaths, new infections and future health care costs, a smart
approach to increasing HIV investment, could avert around
half of the new infections and deaths up to 2030 compared to
business as usual. |
| author2 |
Goroshko, Alona |
| author_facet |
Goroshko, Alona World Bank |
| format |
Working Paper |
| author |
World Bank |
| author_sort |
World Bank |
| title |
Value for Money in Ukraine’s HIV Response : Strategic Investment and Improved Efficiency |
| title_short |
Value for Money in Ukraine’s HIV Response : Strategic Investment and Improved Efficiency |
| title_full |
Value for Money in Ukraine’s HIV Response : Strategic Investment and Improved Efficiency |
| title_fullStr |
Value for Money in Ukraine’s HIV Response : Strategic Investment and Improved Efficiency |
| title_full_unstemmed |
Value for Money in Ukraine’s HIV Response : Strategic Investment and Improved Efficiency |
| title_sort |
value for money in ukraine’s hiv response : strategic investment and improved efficiency |
| publisher |
World Bank, Washington, DC |
| publishDate |
2016 |
| url |
http://documents.worldbank.org/curated/en/2016/07/26570650/value-money-ukraine’s-hiv-response-strategic-investment-improved-efficiency http://hdl.handle.net/10986/24967 |
| _version_ |
1764457978138722304 |